カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

コロイデレミア治療薬のグローバル市場2023：経口、静脈内

■ 英語タイトル：Global Choroideremia Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG12046）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG12046
■ 発行日：2023年8月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆医療
■ ページ数：104
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[コロイデレミア治療薬のグローバル市場2023：経口、静脈内]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、コロイデレミア治療薬のグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界のコロイデレミア治療薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- コロイデレミア治療薬の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

コロイデレミア治療薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・経口、静脈内

用途別セグメント
・病院薬局、小売薬局、オンライン薬局

主要な市場プレーヤー
・Novartis AG、Spark Therapeutics、Bluebird Bio Inc.、Biogen、Copernicus Therapeutics, Inc.、4D Molecular Therapeutics、Wize Pharma Inc.、Retina Implant AG、Hoffmann-La Roche Ltd、Pixium Vision、Merck、Teva

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、コロイデレミア治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なコロイデレミア治療薬メーカーの企業概要、2019年～2022年までのコロイデレミア治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なコロイデレミア治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別コロイデレミア治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのコロイデレミア治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのコロイデレミア治療薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびコロイデレミア治療薬の産業チェーンを掲載しています。
・第14、15章では、コロイデレミア治療薬の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– コロイデレミア治療薬の概要
– 種類別分析（2018年vs2022年vs2029年）：経口、静脈内
– 用途別分析（2018年vs2022年vs2029年）：病院薬局、小売薬局、オンライン薬局
– 世界のコロイデレミア治療薬市場規模・予測
– 世界のコロイデレミア治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Novartis AG、Spark Therapeutics、Bluebird Bio Inc.、Biogen、Copernicus Therapeutics, Inc.、4D Molecular Therapeutics、Wize Pharma Inc.、Retina Implant AG、Hoffmann-La Roche Ltd、Pixium Vision、Merck、Teva
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：経口、静脈内
・用途別分析2018年-2029年：病院薬局、小売薬局、オンライン薬局
・コロイデレミア治療薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・コロイデレミア治療薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・コロイデレミア治療薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・コロイデレミア治療薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・コロイデレミア治療薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Choroideremia Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Choroideremia Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral
1.3.3 Intravenous
1.4 Market Analysis by Application
1.4.1 Overview: Global Choroideremia Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Choroideremia Treatment Market Size & Forecast
1.5.1 Global Choroideremia Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Choroideremia Treatment Sales Quantity (2018-2029)
1.5.3 Global Choroideremia Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Choroideremia Treatment Product and Services
2.1.4 Novartis AG Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis AG Recent Developments/Updates
2.2 Spark Therapeutics
2.2.1 Spark Therapeutics Details
2.2.2 Spark Therapeutics Major Business
2.2.3 Spark Therapeutics Choroideremia Treatment Product and Services
2.2.4 Spark Therapeutics Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Spark Therapeutics Recent Developments/Updates
2.3 Bluebird Bio Inc.
2.3.1 Bluebird Bio Inc. Details
2.3.2 Bluebird Bio Inc. Major Business
2.3.3 Bluebird Bio Inc. Choroideremia Treatment Product and Services
2.3.4 Bluebird Bio Inc. Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bluebird Bio Inc. Recent Developments/Updates
2.4 Biogen
2.4.1 Biogen Details
2.4.2 Biogen Major Business
2.4.3 Biogen Choroideremia Treatment Product and Services
2.4.4 Biogen Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Biogen Recent Developments/Updates
2.5 Copernicus Therapeutics, Inc.
2.5.1 Copernicus Therapeutics, Inc. Details
2.5.2 Copernicus Therapeutics, Inc. Major Business
2.5.3 Copernicus Therapeutics, Inc. Choroideremia Treatment Product and Services
2.5.4 Copernicus Therapeutics, Inc. Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Copernicus Therapeutics, Inc. Recent Developments/Updates
2.6 4D Molecular Therapeutics
2.6.1 4D Molecular Therapeutics Details
2.6.2 4D Molecular Therapeutics Major Business
2.6.3 4D Molecular Therapeutics Choroideremia Treatment Product and Services
2.6.4 4D Molecular Therapeutics Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 4D Molecular Therapeutics Recent Developments/Updates
2.7 Wize Pharma Inc.
2.7.1 Wize Pharma Inc. Details
2.7.2 Wize Pharma Inc. Major Business
2.7.3 Wize Pharma Inc. Choroideremia Treatment Product and Services
2.7.4 Wize Pharma Inc. Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Wize Pharma Inc. Recent Developments/Updates
2.8 Retina Implant AG
2.8.1 Retina Implant AG Details
2.8.2 Retina Implant AG Major Business
2.8.3 Retina Implant AG Choroideremia Treatment Product and Services
2.8.4 Retina Implant AG Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Retina Implant AG Recent Developments/Updates
2.9 Hoffmann-La Roche Ltd
2.9.1 Hoffmann-La Roche Ltd Details
2.9.2 Hoffmann-La Roche Ltd Major Business
2.9.3 Hoffmann-La Roche Ltd Choroideremia Treatment Product and Services
2.9.4 Hoffmann-La Roche Ltd Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hoffmann-La Roche Ltd Recent Developments/Updates
2.10 Pixium Vision
2.10.1 Pixium Vision Details
2.10.2 Pixium Vision Major Business
2.10.3 Pixium Vision Choroideremia Treatment Product and Services
2.10.4 Pixium Vision Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pixium Vision Recent Developments/Updates
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Choroideremia Treatment Product and Services
2.11.4 Merck Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Merck Recent Developments/Updates
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Choroideremia Treatment Product and Services
2.12.4 Teva Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Teva Recent Developments/Updates
3 Competitive Environment: Choroideremia Treatment by Manufacturer
3.1 Global Choroideremia Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Choroideremia Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Choroideremia Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Choroideremia Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Choroideremia Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Choroideremia Treatment Manufacturer Market Share in 2022
3.5 Choroideremia Treatment Market: Overall Company Footprint Analysis
3.5.1 Choroideremia Treatment Market: Region Footprint
3.5.2 Choroideremia Treatment Market: Company Product Type Footprint
3.5.3 Choroideremia Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Choroideremia Treatment Market Size by Region
4.1.1 Global Choroideremia Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Choroideremia Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Choroideremia Treatment Average Price by Region (2018-2029)
4.2 North America Choroideremia Treatment Consumption Value (2018-2029)
4.3 Europe Choroideremia Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Choroideremia Treatment Consumption Value (2018-2029)
4.5 South America Choroideremia Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Choroideremia Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Choroideremia Treatment Sales Quantity by Type (2018-2029)
5.2 Global Choroideremia Treatment Consumption Value by Type (2018-2029)
5.3 Global Choroideremia Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Choroideremia Treatment Sales Quantity by Application (2018-2029)
6.2 Global Choroideremia Treatment Consumption Value by Application (2018-2029)
6.3 Global Choroideremia Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Choroideremia Treatment Sales Quantity by Type (2018-2029)
7.2 North America Choroideremia Treatment Sales Quantity by Application (2018-2029)
7.3 North America Choroideremia Treatment Market Size by Country
7.3.1 North America Choroideremia Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Choroideremia Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Choroideremia Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Choroideremia Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Choroideremia Treatment Market Size by Country
8.3.1 Europe Choroideremia Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Choroideremia Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Choroideremia Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Choroideremia Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Choroideremia Treatment Market Size by Region
9.3.1 Asia-Pacific Choroideremia Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Choroideremia Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Choroideremia Treatment Sales Quantity by Type (2018-2029)
10.2 South America Choroideremia Treatment Sales Quantity by Application (2018-2029)
10.3 South America Choroideremia Treatment Market Size by Country
10.3.1 South America Choroideremia Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Choroideremia Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Choroideremia Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Choroideremia Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Choroideremia Treatment Market Size by Country
11.3.1 Middle East & Africa Choroideremia Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Choroideremia Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Choroideremia Treatment Market Drivers
12.2 Choroideremia Treatment Market Restraints
12.3 Choroideremia Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Choroideremia Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Choroideremia Treatment
13.3 Choroideremia Treatment Production Process
13.4 Choroideremia Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Choroideremia Treatment Typical Distributors
14.3 Choroideremia Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Choroideremia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Choroideremia Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Choroideremia Treatment Product and Services
Table 6. Novartis AG Choroideremia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis AG Recent Developments/Updates
Table 8. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 9. Spark Therapeutics Major Business
Table 10. Spark Therapeutics Choroideremia Treatment Product and Services
Table 11. Spark Therapeutics Choroideremia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Spark Therapeutics Recent Developments/Updates
Table 13. Bluebird Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Bluebird Bio Inc. Major Business
Table 15. Bluebird Bio Inc. Choroideremia Treatment Product and Services
Table 16. Bluebird Bio Inc. Choroideremia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bluebird Bio Inc. Recent Developments/Updates
Table 18. Biogen Basic Information, Manufacturing Base and Competitors
Table 19. Biogen Major Business
Table 20. Biogen Choroideremia Treatment Product and Services
Table 21. Biogen Choroideremia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Biogen Recent Developments/Updates
Table 23. Copernicus Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Copernicus Therapeutics, Inc. Major Business
Table 25. Copernicus Therapeutics, Inc. Choroideremia Treatment Product and Services
Table 26. Copernicus Therapeutics, Inc. Choroideremia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Copernicus Therapeutics, Inc. Recent Developments/Updates
Table 28. 4D Molecular Therapeutics Basic Information, Manufacturing Base and Competitors
Table 29. 4D Molecular Therapeutics Major Business
Table 30. 4D Molecular Therapeutics Choroideremia Treatment Product and Services
Table 31. 4D Molecular Therapeutics Choroideremia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. 4D Molecular Therapeutics Recent Developments/Updates
Table 33. Wize Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Wize Pharma Inc. Major Business
Table 35. Wize Pharma Inc. Choroideremia Treatment Product and Services
Table 36. Wize Pharma Inc. Choroideremia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Wize Pharma Inc. Recent Developments/Updates
Table 38. Retina Implant AG Basic Information, Manufacturing Base and Competitors
Table 39. Retina Implant AG Major Business
Table 40. Retina Implant AG Choroideremia Treatment Product and Services
Table 41. Retina Implant AG Choroideremia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Retina Implant AG Recent Developments/Updates
Table 43. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Hoffmann-La Roche Ltd Major Business
Table 45. Hoffmann-La Roche Ltd Choroideremia Treatment Product and Services
Table 46. Hoffmann-La Roche Ltd Choroideremia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 48. Pixium Vision Basic Information, Manufacturing Base and Competitors
Table 49. Pixium Vision Major Business
Table 50. Pixium Vision Choroideremia Treatment Product and Services
Table 51. Pixium Vision Choroideremia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Pixium Vision Recent Developments/Updates
Table 53. Merck Basic Information, Manufacturing Base and Competitors
Table 54. Merck Major Business
Table 55. Merck Choroideremia Treatment Product and Services
Table 56. Merck Choroideremia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Merck Recent Developments/Updates
Table 58. Teva Basic Information, Manufacturing Base and Competitors
Table 59. Teva Major Business
Table 60. Teva Choroideremia Treatment Product and Services
Table 61. Teva Choroideremia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Teva Recent Developments/Updates
Table 63. Global Choroideremia Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Choroideremia Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Choroideremia Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Choroideremia Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Choroideremia Treatment Production Site of Key Manufacturer
Table 68. Choroideremia Treatment Market: Company Product Type Footprint
Table 69. Choroideremia Treatment Market: Company Product Application Footprint
Table 70. Choroideremia Treatment New Market Entrants and Barriers to Market Entry
Table 71. Choroideremia Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Choroideremia Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Choroideremia Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Choroideremia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Choroideremia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Choroideremia Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Choroideremia Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Choroideremia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Choroideremia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Choroideremia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Choroideremia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Choroideremia Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Choroideremia Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Choroideremia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Choroideremia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Choroideremia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Choroideremia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Choroideremia Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Choroideremia Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Choroideremia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Choroideremia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Choroideremia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Choroideremia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Choroideremia Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Choroideremia Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Choroideremia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Choroideremia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Choroideremia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Choroideremia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Choroideremia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Choroideremia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Choroideremia Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Choroideremia Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Choroideremia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Choroideremia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Choroideremia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Choroideremia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Choroideremia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Choroideremia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Choroideremia Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Choroideremia Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Choroideremia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Choroideremia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Choroideremia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Choroideremia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Choroideremia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Choroideremia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Choroideremia Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Choroideremia Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Choroideremia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Choroideremia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Choroideremia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Choroideremia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Choroideremia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Choroideremia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Choroideremia Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Choroideremia Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Choroideremia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Choroideremia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Choroideremia Treatment Raw Material
Table 131. Key Manufacturers of Choroideremia Treatment Raw Materials
Table 132. Choroideremia Treatment Typical Distributors
Table 133. Choroideremia Treatment Typical Customers
List of Figures
Figure 1. Choroideremia Treatment Picture
Figure 2. Global Choroideremia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Choroideremia Treatment Consumption Value Market Share by Type in 2022
Figure 4. Oral Examples
Figure 5. Intravenous Examples
Figure 6. Global Choroideremia Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Choroideremia Treatment Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacies Examples
Figure 9. Retail Pharmacies Examples
Figure 10. Online Pharmacies Examples
Figure 11. Global Choroideremia Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Choroideremia Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Choroideremia Treatment Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Choroideremia Treatment Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Choroideremia Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Choroideremia Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Choroideremia Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Choroideremia Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Choroideremia Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Choroideremia Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Choroideremia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Choroideremia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Choroideremia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Choroideremia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Choroideremia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Choroideremia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Choroideremia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Choroideremia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Choroideremia Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Choroideremia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Choroideremia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Choroideremia Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Choroideremia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Choroideremia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Choroideremia Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Choroideremia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Choroideremia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Choroideremia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Choroideremia Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Choroideremia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Choroideremia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Choroideremia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Choroideremia Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Choroideremia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Choroideremia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Choroideremia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Choroideremia Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Choroideremia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Choroideremia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Choroideremia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Choroideremia Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Choroideremia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Choroideremia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Choroideremia Treatment Market Drivers
Figure 74. Choroideremia Treatment Market Restraints
Figure 75. Choroideremia Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Choroideremia Treatment in 2022
Figure 78. Manufacturing Process Analysis of Choroideremia Treatment
Figure 79. Choroideremia Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source

※参考情報

コロイデレミア治療薬は、コロイデレミアという遺伝性の網膜疾患に対する治療法の一形態であり、患者の視力を保護および改善することを目的としています。コロイデレミアは、X染色体に位置するRPE65遺伝子の変異に起因しており、これにより網膜の色素上皮における機能が障害され、最終的には視神経の機能に深刻な影響を及ぼします。この疾患は主に男性に影響を及ぼし、視力喪失は通常、思春期から青年期にかけて始まります。

治療法の概念は、主に遺伝子治療を通じてこの疾患の根本的な原因を解決することに焦点を当てています。具体的には、正常なRPE65遺伝子を網膜の色素上皮細胞に導入することで、正常なタンパク質を生成させ、網膜の正常な機能を回復することを目的としています。これによって、視覚の維持や、視力の改善が期待されます。

コロイデレミア治療薬の特徴として、まず第一に遺伝子治療が挙げられます。遺伝子治療は、患者の体内に新しい遺伝子を導入することで、疾患の原因となる遺伝的な欠損を補う手法です。コロイデレミアの場合、通常はウイルスベクターを用いてターゲットとなる細胞に遺伝子を伝達します。この方法は、従来の薬剤療法とは異なり、根本的な治療を目指す点が大きな特徴となっています。

さらに、適応症としては、コロイデレミアの診断が確定した患者が対象となります。これには、患者が自分の視力低下の経過を自覚し、診断を受けた後、症状の進行を抑えることが期待されます。視力の改善が見込まれる患者に対して、治療を行うことで、患者の生活の質を向上させることができます。

関連する技術には、遺伝子編集技術も含まれます。CRISPR/Cas9などの技術を用いることで、特定の遺伝子を直接修正することができる可能性があります。これにより、コロイデレミア治療は、単なる遺伝子導入に留まらず、遺伝子の修正や編集による疾患の根本治療へと発展する可能性も秘めています。

現在のコロイデレミア治療薬には、主に遺伝子治療製品が含まれますが、将来的には他の治療戦略も考えられています。例えば、代替的な療法として、網膜の機能を補完する人工網膜の開発や、神経保護剤の使用などが提案されています。神経保護剤は、網膜の神経細胞を保護し、視機能の維持を助けるものです。これらの治療法は、遺伝子治療の効果を最大限に引き出すためのアプローチとして検討されています。

コロイデレミア治療薬は、患者に新たな希望をもたらすものであり、研究開発は進行中です。遺伝子治療だけでなく、さまざまなアプローチを組み合わせることで、より効果的な治療法の確立が期待されます。新しい治療法が確立されることで、患者の視力をより良く保護し、改善することができるようになるでしょう。この病に苦しむ方々にとって、明るい未来が訪れることを願っています。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 絨毛出血症治療の世界市場2023-2029：経口、静脈内
  • アルコール依存症治療のグローバル市場2023：薬物療法、治療、集学的治療
  • シュニッツラー症候群治療のグローバル市場2023：アナキンラ、リロシップ、カナキヌマブ、その他
  • 伝染性軟属腫（MC）治療のグローバル市場2023：凍結療法、免疫調節療法、局所療法
  • 鼻アレルギー治療のグローバル市場2023：OTC、処方
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG12046 )"コロイデレミア治療薬のグローバル市場2023：経口、静脈内" (英文：Global Choroideremia Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。